Target intelligence / Profile preview

Riboflavin (Vitamin B2) (B2)

Target
B2
Molecular classification
Vitamin, Cofactor precursor, Flavin
01

Overview

Riboflavin, or Vitamin B2, is a crucial water-soluble micronutrient that serves as the primary precursor for the essential coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (NIH Office of Dietary Supplements, 2022). These coenzymes are integral to numerous redox reactions across various metabolic pathways, including the mitochondrial electron transport chain, the tricarboxylic acid (TCA) cycle, and fatty acid oxidation (StatPearls, 2023). Beyond energy production, riboflavin is necessary for the conversion of other B vitamins into their active forms and contributes to the body's antioxidant defense system by serving as a cofactor for glutathione reductase (PubChem, CID 493570). Clinically, riboflavin is utilized to address nutritional deficiencies and as a prophylactic treatment for migraines, likely due to its role in enhancing mitochondrial energy metabolism (PubMed, PMID 26780873). It is also a critical therapeutic agent for rare genetic disorders involving riboflavin transporters or flavin-dependent enzymes, such as Brown-Vialetto-Van Laere syndrome (Wikipedia, 2024).

Other names
Vitamin B2Lactoflavin7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazineE101
02

Mechanism of action

Riboflavin is converted into the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FAD synthetase. These cofactors are essential for the activity of flavoproteins involved in the mitochondrial electron transport chain, fatty acid beta-oxidation, and the citric acid cycle.

03

Biological functions

Energy metabolismOxidation-reduction reactionsMitochondrial electron transportAntioxidant activityMetabolism of vitamins (B6, folate, niacin)
04

Disease associations

Riboflavin deficiency (Ariboflavinosis)MigraineHyperhomocysteinemiaBrown-Vialetto-Van Laere syndromeMultiple acyl-CoA dehydrogenation deficiency (MADD)
05

Safety considerations

Yellow-orange urine discoloration (flavinuria)Potential interference with light-sensitive medicationsLimited toxicity due to low solubility and rapid renal excretion
06

Interacting drugs

Riboflavin

4 more in the full profile.

07

Biomarkers

Erythrocyte glutathione reductase activity coefficient (EGRAC)Urinary riboflavin excretionPlasma riboflavin concentration

Beyond the preview

Go deeper on Riboflavin (Vitamin B2) (B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Riboflavin (Vitamin B2) (B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call